Cryoport Dirección
Dirección controles de criterios 4/4
El CEO de Cryoport's es Jerry Shelton , nombrado en Nov 2012, tiene una permanencia de 11.42 años. compensación anual total es $2.24M, compuesta por 38.7% salario y 61.3% primas, incluidas acciones y opciones de la empresa. posee directamente un 1.41% de las acciones de la empresa, por valor de $11.12M. La antigüedad media del equipo directivo y de la junta directiva es de 4.3 años y 9.5 años, respectivamente.
Información clave
Jerry Shelton
Chief Executive Officer (CEO)
US$2.2m
Compensación total
Porcentaje del salario del CEO | 38.7% |
Permanencia del CEO | 11.4yrs |
Participación del CEO | 1.4% |
Permanencia media de la dirección | 4.3yrs |
Promedio de permanencia en la Junta Directiva | 9.5yrs |
Actualizaciones recientes de la dirección
Recent updates
Potential Upside For Cryoport, Inc. (NASDAQ:CYRX) Not Without Risk
Apr 15Cryoport, Inc. (NASDAQ:CYRX) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?
Mar 15Cryoport Tanks On Chilling Results And Bad Decisions
Mar 14Is Cryoport (NASDAQ:CYRX) Using Debt In A Risky Way?
Mar 10Fewer Investors Than Expected Jumping On Cryoport, Inc. (NASDAQ:CYRX)
Jan 15Health Check: How Prudently Does Cryoport (NASDAQ:CYRX) Use Debt?
Oct 06Downgrade: Here's How Analysts See Cryoport, Inc. (NASDAQ:CYRX) Performing In The Near Term
Jul 23Cryoport, Inc.'s (NASDAQ:CYRX) Subdued P/S Might Signal An Opportunity
Jul 12Is Cryoport (NASDAQ:CYRX) A Risky Investment?
Jun 13Cryoport, Inc.'s (NASDAQ:CYRX) Intrinsic Value Is Potentially 96% Above Its Share Price
Mar 06Cryoport, Inc. (NASDAQ:CYRX) Analysts Just Cut Their EPS Forecasts Substantially
Nov 07Is Cryoport (NASDAQ:CYRX) Using Debt In A Risky Way?
Sep 23Cryoport: A Rare Investing Opportunity
Sep 22Cryoport enters into strategic relationship with Takeda's BioLife Plasma Services
Sep 08Cryoport: Rapid Growth Is Great, But Shares Look Overpriced
Jul 30Cryoport: To Resume Aggressive Growth
May 11Cryoport: An Industry Leader Basking In Industry Tailwinds
Apr 15Cryoport: Risky Investment With Upside Potential
Apr 01Cryoport: More Growth Going Into New Year 2022
Dec 29Is Cryoport, Inc. (NASDAQ:CYRX) Trading At A 49% Discount?
Dec 05What Is Cryoport, Inc.'s (NASDAQ:CYRX) Share Price Doing?
Nov 09Is Cryoport (NASDAQ:CYRX) Using Too Much Debt?
Oct 17Cryoport: The Golden Stock
Oct 08Cryoport: Unfairly Punished, Valuation Update Shows 45% Upside
Oct 01Cryoport: Best Price-Positioned Medical Services Stock, As Seen By Market-Makers
Jul 01Is Cryoport, Inc. (NASDAQ:CYRX) Trading At A 47% Discount?
Jun 08Análisis de compensación del CEO
Fecha | Compensación total | Salario | Ingresos de la empresa |
---|---|---|---|
Dec 31 2023 | US$2m | US$866k | -US$108m |
Sep 30 2023 | n/a | n/a | -US$55m |
Jun 30 2023 | n/a | n/a | -US$47m |
Mar 31 2023 | n/a | n/a | -US$38m |
Dec 31 2022 | US$2m | US$792k | -US$45m |
Sep 30 2022 | n/a | n/a | -US$296m |
Jun 30 2022 | n/a | n/a | -US$297m |
Mar 31 2022 | n/a | n/a | -US$293m |
Dec 31 2021 | US$5m | US$713k | -US$284m |
Sep 30 2021 | n/a | n/a | -US$76m |
Jun 30 2021 | n/a | n/a | -US$78m |
Mar 31 2021 | n/a | n/a | -US$77m |
Dec 31 2020 | US$5m | US$613k | -US$75m |
Sep 30 2020 | n/a | n/a | -US$22m |
Jun 30 2020 | n/a | n/a | -US$23m |
Mar 31 2020 | n/a | n/a | -US$20m |
Dec 31 2019 | US$4m | US$600k | -US$18m |
Sep 30 2019 | n/a | n/a | -US$20m |
Jun 30 2019 | n/a | n/a | -US$9m |
Mar 31 2019 | n/a | n/a | -US$9m |
Dec 31 2018 | US$3m | US$581k | -US$10m |
Sep 30 2018 | n/a | n/a | -US$10m |
Jun 30 2018 | n/a | n/a | -US$9m |
Mar 31 2018 | n/a | n/a | -US$9m |
Dec 31 2017 | US$2m | US$435k | -US$8m |
Compensación vs. Mercado: La compensación total de Jerry($USD2.24M) está por debajo de la media de empresas de tamaño similar en el mercado US ($USD3.43M).
Compensación vs. Ingresos: La compensación de Jerry ha sido consistente con los resultados de la empresa en el último año.
CEO
Jerry Shelton (78 yo)
11.4yrs
Permanencia
US$2,236,758
Compensación
Mr. Jerrell W. Shelton, also known as Jerry, has been the Chief Executive Officer and President of CryoPort, Inc. since November 5, 2012 and has been its Chairman of the Board since October 2015. Mr. Shelt...
Equipo directivo
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
Chairman | 11.4yrs | US$2.24m | 1.41% $ 11.3m | |
CFO & Treasurer | 12.8yrs | US$1.04m | 0.26% $ 2.1m | |
Senior VP and Chief Digital & Technology Officer | less than a year | US$410.01k | 0% $ 0 | |
Chief Scientific Officer | 3.6yrs | US$1.04m | 0.16% $ 1.3m | |
Vice President of Corporate Development & Investor Relations | no data | sin datos | sin datos | |
VP, General Counsel & Corporate Secretary | no data | sin datos | sin datos | |
Vice President of Global Human Resources & Organizational Development | no data | sin datos | sin datos | |
VP & Chief Innovation Officer | 4.3yrs | US$174.52k | sin datos | |
Chief Operating Officer of Cryoport Systems | 4.3yrs | sin datos | sin datos |
4.3yrs
Permanencia media
59.5yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de CYRX se considera experimentado (4.3 años antigüedad media).
Miembros de la Junta
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
Chairman | 11.5yrs | US$2.24m | 1.41% $ 11.3m | |
Senior VP and Chief Digital & Technology Officer | 10.6yrs | US$410.01k | 0% $ 0 | |
Independent Lead Director | 9.3yrs | US$440.01k | 0.20% $ 1.6m | |
Independent Director | 3.1yrs | US$394.99k | 0.028% $ 222.5k | |
Member of Commercial Advisory Board | 11.3yrs | sin datos | sin datos | |
Independent Director | 8.6yrs | US$418.99k | 0.0094% $ 75.5k | |
Independent Director | 3.5yrs | US$70.00k | sin datos | |
Member of Advisory Board | 16.3yrs | sin datos | sin datos | |
Member of Advisory Board | no data | sin datos | sin datos | |
Independent Director | 9.8yrs | US$405.01k | 0.071% $ 574.7k | |
Independent Director | 5.3yrs | US$394.99k | 0.030% $ 238.1k |
9.5yrs
Permanencia media
65yo
Promedio de edad
Junta con experiencia: La junta directiva de CYRX se considera experimentada (9.5 años de antigüedad promedio).